Dr. Reddy's Laboratories Ltd. has announced that the audit of its API Srikakulam Plant (SEZ), Andhra Pradesh, by the US FDA, has been completed on October 25, 2019. The company has been issued a Form 483 with 4 (four) observations. The company has said that it will address them comprehensively within the stipulated timeline.
Shares of DR.REDDY's LABORATORIES LTD. was last trading in BSE at Rs.2786.75 as compared to the previous close of Rs. 2825.45. The total number of shares traded during the day was 10075 in over 736 trades.
The stock hit an intraday high of Rs. 2850 and intraday low of 2780. The net turnover during the day was Rs. 28163750.